- Gomez-Mancilla, B., Dürsteler, K. M., Vogel, M., Herdener, M., Torrens, M., Gálvez, B. P., Gual, A., Corral, R. M., Kuper, E. I., Mosca, D. L., Dumitras, S., Pezous, N., Berkheimer, M., Walker, E., Gasparini, F., Cha, J. H., & Dolmetsch, R. (2025). Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial. Science Translational Medicine, 17(792), eadi4505. https://doi.org/10.1126/scitranslmed.adi4505
Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial
on 7 de juliol de 2025
with No hi ha comentaris
Deixa un comentari